BioCardia Inc (NASDAQ:BCDA)’s traded shares stood at 2.67 million during the latest session, with the company’s beta value hitting 0.79. At the last check today, the stock’s price was $2.12, to imply an increase of 1.74% or $0.04 in intraday trading. The BCDA share’s 52-week high remains $4.66, putting it -119.81% down since that peak but still an impressive 23.58% since price per share fell to its 52-week low of $1.62. The company has a valuation of $10.98M, with an average of 67550.0 shares in intraday trading volume over the past 10 days and average of 69.86K shares over the past 3 months.
Analysts have given a consensus recommendation of Hold for BioCardia Inc (BCDA), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give BCDA a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 0 recommend it as a Buy.
BioCardia Inc (NASDAQ:BCDA) trade information
After registering a 1.74% upside in the latest session, BioCardia Inc (BCDA) has traded red over the past five days. The 5-day price performance for the stock is -4.92%, and -6.18% over 30 days. With these gigs, the year-to-date price performance is -28.61%. Short interest in BioCardia Inc (NASDAQ:BCDA) saw shorts transact 13462.0 shares and set a 0.23 days time to cover.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 40.58% for the past 5-year period. While 2025 is set for a 58.62% return in earnings, projections for the next 5 years are at 31.06% annually.
BCDA Dividends
BioCardia Inc has its next earnings report out on 2025-May-14. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
BioCardia Inc (NASDAQ:BCDA)’s Major holders
BioCardia Inc insiders hold 21.66% of total outstanding shares, with institutional holders owning 4.75% of the shares at 6.06% float percentage. In total, 4.75% institutions holds shares in the company, led by ADVISOR GROUP HOLDINGS, INC.. As of 2024-06-30, the company held over 11189.0 shares (or 0.0445% of shares), all amounting to roughly $3798.0.
We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the BioCardia Inc (BCDA) shares. Going by data provided on Apr 30, 2025 , Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 21.51 shares. This is just over 0.42% of the total shares, with a market valuation of $45814.0. Data from the same date shows that the other fund manager holds a little less at 12.62, or 0.24% of the shares, all valued at about 26872.0.
